Event Type: Q1 FY27 Earnings Conference Call held on Friday, August 14, 2026, discussing unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Date and Time: The call was held on August 14, 2026 (specific time not mentioned in the transcript).

Purpose: Discussion of quarterly results, strategic updates, expansion roadmap, and clinical developments including AI integration.

Management Participants:

  • Dr. Manika Khanna – Chairperson and Managing Director
  • Mr. Rakesh Kumar Sharma – Chief Financial Officer
  • Adfactors PR – Investor Relations Partners

Financial Period Discussed: Q1 FY27 (quarter ended June 30, 2026)

Key Financial Highlights:

  • Revenue from operations: ₹19.4 crores (9.1% YoY growth from ₹17.8 crores in Q1 FY26)
  • Reported EBITDA: ₹2.4 crores (52.96% YoY decline from ₹5.2 crores)
  • Reported EBITDA margin: 12.5% (vs 29% in Q1 FY26)
  • PAT from continuing operations: ₹1.8 crores (42.27% YoY decline from ₹3.1 crores)
  • Adjusted EBITDA (excluding expansion costs): ₹5.35 crores with 27.63% margin
  • Cash and bank balances: ₹8.12 crores as of June 30, 2026
  • Borrowings: ₹6.74 crores
  • Debt-to-equity ratio: 0.04 times

Strategic and Operational Updates:

  • Expansion Progress: Commissioned South Extension hub on July 16, 2026 (first of 19 planned centers under IPO proceeds)
  • Upcoming Launches: Gurgaon hub operational in 10 days, Nagpur hub operational in 25 days
  • Network Status: 8 hubs and 28 spokes currently operational
  • International Expansion: Three international spokes in Paris, Nigeria, and Sydney
  • New Project: Board approved ₹15 crore Gaudium Women Hospital in Lucknow (expected commercialization in FY28-FY29)
  • AI Integration: Fully integrated SiD and ERICA AI embryology tools across centers since April 1, 2026
  • Clinical Outcomes: First-attempt success rate improved to 62% (from 58%), cumulative pregnancy rate at 85%
  • Patient Mix: International patients contribute 25-30% of patient mix

Guidance and Outlook:

  • Maintains FY27 revenue growth guidance of 30% YoY
  • Expects EBITDA margins to return to FY26 levels by year-end
  • FY27 capex guidance: ₹25 crores for 10 new hubs (₹2.5 crores per hub)
  • Expansion target: 10 new hubs in FY27, 8 in FY28, 1 in FY29

Compliance Statement: The company indicated that the transcript contains forward-looking statements and may contain transcription errors. No specific UPSI disclaimer was mentioned.

Availability of Materials: The transcript is available on the company's website at https://www.gaudiumivfcentre.com/investors

Additional Notes Section

Attachments: The filing mentions an enclosure ("Encl: a/a") but doesn't specify details.

Financial Data Disclosure: The announcement contained detailed financial results for Q1 FY27 including revenue, EBITDA, PAT, and balance sheet metrics.